Anna King is a Director at Epsilon Economics. Anna specializes in matters involving complex damages valuation, antitrust and competition, and intellectual property. Her experience covers a broad range of sectors including pharmaceuticals, automotive, financial services, and technology. Anna’s past engagements include forecasting global pharmaceutical sales for an international biotech firm and providing claims data analysis in one of the largest qui tam settlements involving pharmaceutical kickbacks to date.
Prior to Epsilon Economics, Anna worked at Navigant Economics as a Managing Consultant.
Anna holds an A.B in Economics from the University of Chicago; and an M.B.A. specializing in econometrics and finance, also from the University of Chicago.